Vaccine Safety

Blood Mercury Levels Higher in Preterm Infants Receiving Hepatitis B Vaccine

Published in Vaccine Weekly, May 24th, 2000

In the May 2000 issue of The Journal of Pediatrics, researchers report that hepatitis B vaccines containing thimerosal are elevating mercury levels in some preterm infants.

Thimerosal is an organic mercury compound used to enhance product stability in several drugs and vaccines.

A team of investigators from Mercer University, the Georgia Poison Center, Grady Health System, and Emory University collaborated on a study to measure total mercury levels in preterm and term infants who had received the hepatitis B vaccine. Principal investigator was Gregory V. Stajich, PharMD, associate professor of pharmacy practice at Mercer University Southern...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2000-05-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry